Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Urology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Low Midlife PSA Linked to Reduced 20-Year Prostate Cancer Risk
February 2026
A 20-year cohort study shows men with low baseline PSA face minimal prostate cancer risk, supporting personalised screening strategies using PSA and PSA density.
Read more
15 Feb 2025
Extended Pelvic Lymph Node Dissection Linked to Lower Metastasis Risk in Prostatectomy
Extended pelvic lymph node dissection during prostatectomy significantly reduces metastasis risk, new study finds.
13 Feb 2025
Personalising Overactive Bladder Treatment: Why BMI Matters in Choosing the Right Therapy
Women who are overweight with refractory overactive bladder respond better to botulinum toxin injections than pharmaceutical therapy, new research finds.
11 Feb 2025
Rising Incidence of Late-Stage Prostate Cancer in America
These findings suggest that the reduction in PSA screening has had a widespread impact.
9 Feb 2025
Improving Outcomes in Advanced Upper Tract Urothelial Carcinoma
Findings reveal that patients receiving induction chemotherapy before radical nephroureterectomy experienced significantly improved pathological downstaging.
7 Feb 2025
Climate Change and Its Impact on Urological Health
Benign urological conditions are also influenced by climate change as research indicates a correlation between rising temperatures and dehydration-related conditions.
5 Feb 2025
New Genetic Link to Hereditary Prostate Cancer Identified
A new study has identified pathogenic variants in WNT9B as significant risk factors for hereditary prostate cancer.
3 Feb 2025
Black Males Overlooked in Prostate Cancer Clinical Trials
Black males have the highest incidence and mortality rates for prostate cancer in the USA, but their participation in clinical trials remains disproportionately low.
1 Feb 2025
A New Novel Biomarker for Kidney Stones in Hyperparathyroidism
A high calcium-to-magnesium ratio predicts nephrolithiasis in primary hyperparathyroidism, offering enhanced diagnostic accuracy and specificity.
Loading posts...
« Previous
1
…
20
21
22
23
24
…
45
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View